Gouvernance Lakefront Biotherapeutics NV

LKFT

BE0003818359

Recherche biotechnologique et médicale

Temps réel Euronext Amsterdam Autres places de cotation 13:21:31 29/07/2026			Varia. 5j.	Varia. 1 janv.
25,02 ^EUR	+1,30%		-2,42%	-10,64%

13/07	Lakefront Biotherapeutics NV annonce la démission de Paulo Fontoura de son poste d'administrateur	CI
16/06	Lakefront Biotherapeutics NV (ENXTAM:LKFT) annonce un programme de rachat d'actions	CI

Comité Exécutif: Lakefront Biotherapeutics NV

Dirigeant

Fonctions occupéesDepuis

Henry Gosebruch

53 ans

Chief Executive Officer

12/05/2025

Christina Carlson

Chief Operating Officer

01/06/2026

Sherri Spear

Investor Relations Contact

Eric Hedrick

61 ans

Chief Tech/Sci/R&D Officer

08/06/2026

Tania Philipp

54 ans

Human Resources Officer

04/03/2026

Fred Blakeslee

49 ans

General Counsel

16/10/2025

Aaron Cox

41 ans

Director of Finance/CFO

07/07/2025

Composition du Conseil d'Administration: Lakefront Biotherapeutics NV

Administrateur

ComitésDepuis

Gino Santini

69 ans

Compensation Committee	03/09/2024
Governance Committee Chair	03/09/2024
Nominating Committee Chair	03/09/2024

Dawn Svoronos

72 ans

Governance Committee Chair
Nominating Committee Chair
Audit Committee	28/07/2025
Compensation Committee Chair	28/07/2025

Jane Griffiths

71 ans

Audit Committee	28/07/2025
Nominating Committee	01/04/2020
Compensation Committee	28/07/2025
Nominating Committee Chair	28/07/2025

Oleg Nodelman

49 ans

Governance Committee	17/02/2025
Nominating Committee	17/02/2025

Neil Johnston

59 ans

Audit Committee Chair

01/11/2025

Linda Higgins

63 ans

Compensation Committee

22/10/2019

Devang Bhuva

40 ans

Director/Board Member

01/11/2025

Henry Gosebruch

53 ans

Director/Board Member

12/05/2025

Dernières Nominations: Lakefront Biotherapeutics NV

13/07	Lakefront Biotherapeutics NV annonce la démission de Paulo Fontoura de son poste d'administrateur	CI
08/06	Lakefront Biotherapeutics NV annonce la nomination d'Eric Hedrick au poste de Chief Medical Officer	CI
28/04	Galapagos Nv annonce la nomination de Gino Santini en qualité d'administrateur indépendant non exécutif	CI
26/03	Galapagos NV annonce le départ à la retraite de son président Jérôme Contamine, effectif le 28 avril 2026	CI
06/03	Galapagos nomme une nouvelle directrice des ressources humaines	MT
05/03	Galapagos Nv annonce des changements à la direction et au management, effectifs au 4 mars 2026	CI
19/02	Galapagos NV nomme le Dr Paulo Fontoura en tant qu'administrateur indépendant non-exécutif, à compter du 9 février 2026	CI

Plus d'Actualités

Anciens Dirigeants et Administrateurs: Lakefront Biotherapeutics NV

Insider

Fonctions occupées

DepuisJusqu'au

Paulo Fontoura

Director/Board Member	09/02/2026	13/07/2026
Independent Dir/Board Member	09/02/2026	13/07/2026

Annelies Denecker

Corporate Secretary

01/09/2022

31/05/2026

Jérôme Contamine

Director/Board Member	26/04/2022	13/05/2025
Chairman	13/05/2025	28/04/2026
Independent Dir/Board Member	26/04/2022	28/04/2026

Marieke Vermeersch

Public Communications Contact

01/12/2021

31/03/2026

Annelies Missotten

Human Resources Officer

01/02/2018

31/12/2025

Patrik Ringblom

Corporate Officer/Principal

01/10/2023

30/11/2025

Lena Elisabeth Svanberg

Director/Board Member	28/04/2020	01/11/2025
Independent Dir/Board Member	28/04/2020	01/11/2025

Susanne Antonie Schaffert

Director/Board Member	12/06/2023	01/11/2025
Independent Dir/Board Member	12/06/2023	01/11/2025

Andrew Dickinson

Director/Board Member

27/03/2024

01/11/2025

Valeria Cnossen

General Counsel

01/01/2023

16/10/2025

Thad Huston

Chief Operating Officer	01/07/2023	01/08/2025
Director of Finance/CFO	01/07/2023	07/07/2025

Peter Guenter

Director/Board Member	30/04/2019	28/07/2025
Independent Dir/Board Member	30/04/2019	28/07/2025

Simon Sturge

Director/Board Member	19/09/2023	28/07/2025
Independent Dir/Board Member	19/09/2023	28/07/2025

Paulus Stoffels

Chief Executive Officer	01/04/2022	13/05/2025
Chairman	26/04/2022	13/05/2025

Sofie van Gijsel

Public Communications Contact

01/09/2018

28/02/2025

Daniel Baker

Director/Board Member	26/04/2022	06/10/2024
Independent Dir/Board Member	26/04/2022	06/10/2024

Tina S French

Corporate Officer/Principal

01/08/2023

01/08/2024

Daniel O'Day

Director/Board Member	22/10/2019	26/03/2024
Independent Dir/Board Member	22/10/2019	25/04/2023

Robert Hughes

Chief Tech/Sci/R&D Officer

01/01/2024

Michele Manto

Corporate Officer/Principal

01/09/2017

31/12/2023

Mary Kerr

Director/Board Member	26/07/2016	18/09/2023
Independent Dir/Board Member	26/07/2016	18/09/2023

Bart Filius

Chief Operating Officer	01/09/2017	30/06/2023
Director of Finance/CFO	01/12/2014	30/06/2023
President	01/02/2021	30/06/2023

Raj Bhikhu Parekh

Director/Board Member	26/04/2022	10/06/2023
Chairman	01/01/2004	26/04/2022
Independent Dir/Board Member	26/04/2022	10/06/2023

Walid Abi-Saab

Chief Tech/Sci/R&D Officer

01/03/2017

31/12/2022

Andre Hoekema

Corporate Officer/Principal

01/03/2005

31/12/2022

Howard Mitchell Rowe

Director/Board Member	07/09/2010	26/04/2022
Independent Dir/Board Member	07/09/2010	26/04/2022

Katrine Bosley

Director/Board Member	27/02/2013	26/04/2022
Independent Dir/Board Member	27/02/2013	26/04/2022

Onno van de Stolpe

Director/Board Member	30/06/1999	28/04/2020
Chief Executive Officer	30/06/1999	01/04/2022
Founder	30/06/1999	01/04/2022

Philippe Alen

Corporate Officer/Principal

01/01/2022

Piet Wigerinck

Chief Tech/Sci/R&D Officer	19/04/2012	31/12/2021
Corporate Officer/Principal	01/04/2008	19/04/2012

Elizabeth Goodwin

Investor Relations Contact	-	01/12/2021
Public Communications Contact	-	01/12/2021

Carmen Vroonen

Public Communications Contact

01/02/2019

01/10/2021

Ellen Lefever

General Counsel	01/05/2014	01/04/2019
Corporate Officer/Principal	01/04/2019	01/06/2021

Paul van der Horst

Public Communications Contact	01/03/2016	01/04/2019
Corporate Officer/Principal	01/04/2019	01/04/2021

Sandra Cauwenberghs

Investor Relations Contact

01/12/2020

Harrold van Barlingen

Director/Board Member	01/01/2005	24/04/2018
Independent Dir/Board Member	01/01/2005	24/04/2018

Christine Mummery

Director/Board Member	30/09/2015	-
Independent Dir/Board Member	30/09/2015	-

Vicki Sato

Director/Board Member	27/04/2011	31/12/2014
Independent Dir/Board Member	26/04/2011	31/12/2014

Guillaume Jetten

Director of Finance/CFO

07/07/2009

01/05/2014

Ferdinand Verdonck

Director/Board Member	01/01/2005	04/03/2013
Independent Dir/Board Member	01/01/2005	04/03/2013

Christopher Gregory Newton

Corporate Officer/Principal

14/06/2010

14/12/2012

Graham Dixon

Chief Tech/Sci/R&D Officer

14/03/2012

Ronald Hendrik Peter Brus

Director/Board Member

29/04/2010

25/05/2011

Radan Spaventi

Corporate Officer/Principal

15/12/2010

William Rapeport

Director/Board Member

06/07/2009

30/06/2010

Rudi Pauwels

Director/Board Member	30/06/1999	27/04/2010
Founder	30/06/1999	-

Leo Steenbergen

Director of Finance/CFO

01/06/2007

01/06/2009

Henry Geoffrey McMillan

Director/Board Member

01/06/2009

Laurent Gerard Ganem

Director/Board Member

01/06/2009

Werner Cautreels

Director/Board Member	01/01/2009	-
Independent Dir/Board Member	01/01/2009	-

David Smith

Director of Finance/CFO

01/01/2006

01/05/2007

David Stone

Director/Board Member

23/12/2006

Wilson Totten

Director/Board Member

23/12/2006

Helmuth van Es

Founder

30/06/1999

Marie-Théodora Vandewiele

Corporate Secretary

Katherine Hilyard

Corporate Officer/Principal

Ramzi Amri

Corporate Officer/Principal

Cees Wortel

Chief Tech/Sci/R&D Officer

Stephen William Bunting

Director/Board Member

Laurens George Theunis

Corporate Officer/Principal

Kyra Obolensky

Public Communications Contact

Peter K. M. Verhaeghe

Director/Board Member

19/10/2009

Evelyn Fox

Public Communications Contact

Xavier Marie Bernard Cecile Maes

General Counsel	-	-
Corporate Secretary	-	-

Phil Dudfield

Corporate Officer/Principal

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme	13
Femme	5

Dont comité exécutif

Homme	4
Femme	3

Dont Administrateurs

Homme	7
Femme	1

Révisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Non

Controverses sur les droits de l'Homme

Non

Controverses Subventions fiscales

Non

Conforme à la finance Islamique

Lakefront Biotherapeutics NV (ex Galapagos NV) est une société de biotechnologie créée dans le but de proposer des médicaments efficaces aux patients atteints de maladies graves dans des domaines thérapeutiques où les besoins ne sont pas satisfaits. La société combine une expertise de classe mondiale en matière de transactions avec des capitaux afin d'identifier, d'acquérir et de développer des opportunités prometteuses susceptibles de créer de la valeur pour les patients et les actionnaires. En appliquant une approche de sélection d'actifs indépendante de la modalité thérapeutique et en faisant preuve de flexibilité opérationnelle, Lakefront Biotherapeutics NV donne la priorité aux programmes en oncologie, en immunologie et en inflammation présentant une preuve de concept clinique claire dans des domaines émergents.

Employés

452

Secteur

Recherche biotechnologique et médicale

Agenda

10/08 Publication des résultats - Q2 2026

Plus d'informations sur la société